Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting
Sauzet O, Kleine M, Williams JE (2016)
BMC Cancer 16(1): 771.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Autor*in
Sauzet, OdileUniBi;
Kleine, MarenUniBi;
Williams, John E.
Einrichtung
Abstract / Bemerkung
Background
Given the prevalence of untreated pain among cancer patients, there have been calls for more and better research in the domain. Increasingly, calls for less waste and more optimal use of trial data collected are being made. Waste of data includes non-optimal statistical analysis and non-presentation of interpretable effect size as a measure of effectiveness of an intervention which also enable comparisons across studies.
Methods
We reviewed the recent literature on randomised trials on longitudinal cancer pain to identify sources of loss of data information by collecting material on the nature of outcomes collected, analysed, the method of analysis and what was presented as a result of the trial. Illustrated with real data, we propose some guidelines on how to adequately analyse longitudinal data and report the results using mixed models.
Results
We identified some major source of data information loss, one of which is the transformation of a continuous pain outcome. Not adjusting for the collected outcome baseline value is moreover a source of bias. Multiple testing by analysing the data cross-sectionnally at each time-point leads to loss of information and power. Finally, effect sizes reflecting the effectiveness of the intervention were never reported.
Conclusions
We identified several sources of information loss in the way longitudinal trials on pain were analysed and reported. However these problems could be easily solved by using regression methods like mixed models and presenting regression parameters to provide a concrete quantitative effect of the intervention.
Stichworte
Cancer pain Longitudinal RCTs Statistical analysis
Erscheinungsjahr
2016
Zeitschriftentitel
BMC Cancer
Band
16
Ausgabe
1
Art.-Nr.
771
ISSN
1471-2407
eISSN
1471-2407
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2906169
Zitieren
Sauzet O, Kleine M, Williams JE. Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting. BMC Cancer. 2016;16(1): 771.
Sauzet, O., Kleine, M., & Williams, J. E. (2016). Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting. BMC Cancer, 16(1), 771. doi:10.1186/s12885-016-2818-8
Sauzet, Odile, Kleine, Maren, and Williams, John E. 2016. “Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting”. BMC Cancer 16 (1): 771.
Sauzet, O., Kleine, M., and Williams, J. E. (2016). Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting. BMC Cancer 16:771.
Sauzet, O., Kleine, M., & Williams, J.E., 2016. Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting. BMC Cancer, 16(1): 771.
O. Sauzet, M. Kleine, and J.E. Williams, “Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting”, BMC Cancer, vol. 16, 2016, : 771.
Sauzet, O., Kleine, M., Williams, J.E.: Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting. BMC Cancer. 16, : 771 (2016).
Sauzet, Odile, Kleine, Maren, and Williams, John E. “Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting”. BMC Cancer 16.1 (2016): 771.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Volltext(e)
Name
Access Level
Open Access
Zuletzt Hochgeladen
2019-09-06T09:18:40Z
MD5 Prüfsumme
27e76928c9ea061b53fcfb096341d4f9
Daten bereitgestellt von European Bioinformatics Institute (EBI)
1 Zitation in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Pain prevalence in cancer patients: status quo or opportunities for improvement?
Haumann J, Joosten EBA, Everdingen MHJVDB., Curr Opin Support Palliat Care 11(2), 2017
PMID: 28306569
Haumann J, Joosten EBA, Everdingen MHJVDB., Curr Opin Support Palliat Care 11(2), 2017
PMID: 28306569
18 References
Daten bereitgestellt von Europe PubMed Central.
Management of cancer pain: ESMO Clinical Practice Guidelines.
Jost L, Roila F; ESMO Guidelines Working Group., Ann. Oncol. 21 Suppl 5(), 2010
PMID: 20555093
Jost L, Roila F; ESMO Guidelines Working Group., Ann. Oncol. 21 Suppl 5(), 2010
PMID: 20555093
Prevalence of undertreatment in cancer pain. A review of published literature.
Deandrea S, Montanari M, Moja L, Apolone G., Ann. Oncol. 19(12), 2008
PMID: 18632721
Deandrea S, Montanari M, Moja L, Apolone G., Ann. Oncol. 19(12), 2008
PMID: 18632721
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.
Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS., J. Clin. Oncol. 30(16), 2012
PMID: 22508819
Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS., J. Clin. Oncol. 30(16), 2012
PMID: 22508819
Prevalence of pain in patients with cancer: a systematic review of the past 40 years.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J., Ann. Oncol. 18(9), 2007
PMID: 17355955
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J., Ann. Oncol. 18(9), 2007
PMID: 17355955
AUTHOR UNKNOWN, 0
American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force.
Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, Lipman AG, Bookbinder M, Sanders SH, Turk DC, Carr DB., Arch. Intern. Med. 165(14), 2005
PMID: 16043674
Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, Lipman AG, Bookbinder M, Sanders SH, Turk DC, Carr DB., Arch. Intern. Med. 165(14), 2005
PMID: 16043674
CI, Ann Oncol Off J Eur Soc Med Oncology/ESMO 23(Suppl 7), 2012
AUTHOR UNKNOWN, 0
Assessment of pain.
Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A., Br J Anaesth 101(1), 2008
PMID: 18487245
Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A., Br J Anaesth 101(1), 2008
PMID: 18487245
Statistics notes: Analysing controlled trials with baseline and follow up measurements.
Vickers AJ, Altman DG., BMJ 323(7321), 2001
PMID: 11701584
Vickers AJ, Altman DG., BMJ 323(7321), 2001
PMID: 11701584
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT., Pain 113(1-2), 2005
PMID: 15621359
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT., Pain 113(1-2), 2005
PMID: 15621359
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, Clark J, Clarke M, Cook D, D'Amico R, Deeks JJ, Devereaux PJ, Dickersin K, Egger M, Ernst E, Gotzsche PC, Grimshaw J, Guyatt G, Higgins J, Ioannidis JP, Kleijnen J, Lang T, Liberati A, Magrini N, McNamee D, Moja L, Moher D, Mulrow C, Napoli M, Oxman A, Pham B, Rennie D, Sampson M, Schulz KF, Shekelle PG, Tetzlaff J, Tovey D, Tugwell P., Ann. Intern. Med. 151(4), 2009
PMID: 19622511
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, Clark J, Clarke M, Cook D, D'Amico R, Deeks JJ, Devereaux PJ, Dickersin K, Egger M, Ernst E, Gotzsche PC, Grimshaw J, Guyatt G, Higgins J, Ioannidis JP, Kleijnen J, Lang T, Liberati A, Magrini N, McNamee D, Moja L, Moher D, Mulrow C, Napoli M, Oxman A, Pham B, Rennie D, Sampson M, Schulz KF, Shekelle PG, Tetzlaff J, Tovey D, Tugwell P., Ann. Intern. Med. 151(4), 2009
PMID: 19622511
Routine screening for pain combined with a pain treatment protocol in head and neck cancer: a randomised controlled trial.
Williams JE, Peacock J, Gubbay AN, Kuo PY, Ellard R, Gupta R, Riley J, Sauzet O, Raftery J, Yao G, Ross J., Br J Anaesth 115(4), 2015
PMID: 26385671
Williams JE, Peacock J, Gubbay AN, Kuo PY, Ellard R, Gupta R, Riley J, Sauzet O, Raftery J, Yao G, Ross J., Br J Anaesth 115(4), 2015
PMID: 26385671
The cost of dichotomising continuous variables.
Altman DG, Royston P., BMJ 332(7549), 2006
PMID: 16675816
Altman DG, Royston P., BMJ 332(7549), 2006
PMID: 16675816
Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint.
Ragland DR., Epidemiology 3(5), 1992
PMID: 1391136
Ragland DR., Epidemiology 3(5), 1992
PMID: 1391136
AUTHOR UNKNOWN, 0
Longitudinal randomised controlled trials in rehabilitation post-stroke: a systematic review on the quality of reporting and use of baseline outcome values.
Sauzet O, Kleine M, Menzel-Begemann A, Exner AK., BMC Neurol 15(), 2015
PMID: 26126875
Sauzet O, Kleine M, Menzel-Begemann A, Exner AK., BMC Neurol 15(), 2015
PMID: 26126875
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 27716116
PubMed | Europe PMC
Suchen in